SMC - June 2022 decisions

13 June 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

First treatment option indicated for CKD in Scotland for 20 years

10 May 2022 - NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy ...

Read more →

SMC - May 2022 decisions

9 May 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC - April 2022 decisions

12 April 2022 - Advice on three new medicines for use in conditions including a rare and fatal genetic condition affecting ...

Read more →

New access tool launched as part of SMC’s joint work on streamlining patient access to innovative medicines

8 March 2022 - A new UK wide health technology assessment access forum has been developed by partners including the ...

Read more →

SMC accepts Lumykras (sotorasib) for locally advanced or metastatic non-small cell lung cancer for use on an interim basis by NHS Scotland

7 March 2022 - Sotorasib Is indicated as monotherapy for the treatment of adult patients with KRAS G12C mutated locally advanced ...

Read more →

SMC approval welcome news for breast cancer patients

9 March 2022 - Trodelvy is accepted for use in metastatic triple negative breast cancer. patients who have already received two ...

Read more →

Key considerations in the health technology assessment of advanced therapy medicinal products in Scotland, The Netherlands and England

8 March 2022 - Advanced therapy medicinal products are highly innovative therapies. Their costs and uncertain value claims have raised concerns ...

Read more →

Scottish Medicines Consortium update

7 March 2022 - Diurnal provides an update on the status of reimbursement of Efmody (modified release hydrocortisone) for NHS ...

Read more →

SMC - March 2022 decisions

7 March 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

SMC approves Biogen’s Vumerity for patients with multiple sclerosis

9 February 2022 - The new, at home oral treatment has been developed for adults in Scotland living with relapsing-remitting multiple ...

Read more →

Angelini Pharma’s Ontozry available for patients in Scotland with drug resistant epilepsy

9 February 2022 - SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy ...

Read more →

Cannabis-based medicine among batch of new drugs approved for use in Scotland

8 February 2022 - The medicines have been approved for use by the Scottish Medicines Consortium. ...

Read more →

SMC - February 2022 decisions

7 February 2022 - Advice on six new medicines for use in conditions including a rare lung cancer caused by ...

Read more →

Breast cancer patients in Scotland are set to receive tumour blasting wonder drug that starts working in weeks - sparking hopes of a wider rollout for NHS patients across the rest of the UK

23 January 2022 - A breast cancer drug that can melt away tumours in weeks has been given the green ...

Read more →